Introduction
============

Acute pulmonary thromboembolism (PTE) is a common disease with a 3-month death rate of up to 17.4%.[@b1-ARYA-14-078],[@b2-ARYA-14-078] Even if patients are treated with anticoagulation, the death rate in hemodynamically ranges from 8.1% to 15.1%.[@b2-ARYA-14-078] Furthermore, over 42 million deaths were reported from the United States within a 20-year period, in a previously conducted study.[@b1-ARYA-14-078] About 1.5% of patients were diagnosed with PTE, and PTE was the presumed cause of death for 200,000 patients.[@b1-ARYA-14-078] Considering local regions, a study based on three National Healthcare Group hospitals in 2006, estimated the population-based incidence of PTE to be 15 per 100,000.[@b3-ARYA-14-078] In addition, lower rates of venous thromboembolism were found for Asians, compared to Caucasians and Eurasians.[@b3-ARYA-14-078]

Since PTE is associated with variable and nonspecific symptoms, accurate diagnosis is challenging. Yet, computed tomography (CT) angiography is used as a common diagnostic technique for PTE. Furthermore, several right ventricular (RV) echocardiographic parameters have been proposed as sensitive markers, to detect nonspecific signs and symptoms of this illness. Studies showed that acute PTE increases the pressure of the pulmonary arterial system and RV that results in RV dysfunction, and may progress further to right heart failure and circulatory collapse. Thus, these studies suggest that patients with PTE experience RV echocardiographic changes;[@b3-ARYA-14-078] however, there has not been a specific study to further analyze these changes. In our study, we evaluated RV echocardiographic finding, in patients with PTE, diagnosed by CT angiography.

Materials and Methods
=====================

This cross-sectional study was conducted in Department of Cardiology, Alzahra Hospital, Isfahan, Center of Iran, from August to December 2015. The transthoracic echocardiography (TTE) findings of patients who had PTE diagnosed by CT angiography, were compared to patients without PTE.

Inclusion criteria consisted of patient referred to cardiology department of Alzahra hospital with a probability diagnosis of PTE, with age of 18-70 years, and satisfaction to enter the study. Exclusion criteria consisted of low quality images based on patient\'s condition, patients with chronic lung disease, history of heart failure, or heart attack, history of high pulmonary arterial pressure, including a previous history of pulmonary embolism[@b4-ARYA-14-078]-[@b6-ARYA-14-078] proven by CT angiography, life expectancy of less than 3 months, pregnancy, kidney malfunction (creatinine clearance of 30 ml/minute), unable to complete CT testing (e.g., allergy to intravenous contrast material, unavailability of CT, patient too ill), or hemodynamic instability at presentation (such as cardiogenic shock, systolic blood pressure of more than 90 mmHg,[@b7-ARYA-14-078] or use of inotropic drug). Patients that did not tolerate the protocol-required TTE, were excluded from this study.

The study flowchart is shown in [figure 1](#f1-ARYA-14-078){ref-type="fig"}. 160 patients with a probability diagnosis of PTE, diagnosed by internist and based on inclusion and exclusion criteria were included. Then, CT angiography was performed for all patients, and PTE was confirmed by showing a complete or partial filling defect in the pulmonary vessels.

Patients with signs and symptoms of pulmonary embolism undergone 64 multi-slice CT pulmonary angiography, after intravenous injection of Wheezy Pack contrast agent.[@b4-ARYA-14-078] 150 patients had completed data and entered to the study; 93 from PTE group and 57 from individuals without PTE. Pulmonary arterial CT obstruction index (PACTOIR) was calculated in case group by in charge radiologist. Case group were divided into two subtype of oderate to severe PTE (PACTOIR: ≥ 40), and mild to moderate PTE (PACTOIR: \< 40).

The patients underwent TTE (Vivid 3, GE Medical Systems, Horten, Norway) in left lateral decubitus position, with measurements of parameters based on the recommendations of the American Society of Echocardiography, up to 24 hours after acute PTE diagnosis.[@b5-ARYA-14-078] The left ventricular (LV) and RV distances were measured in the 4-chamber apical view at papillary muscle level, to obtain the RV/LV ratio. The parasternal, apical, and subcostal views were used for the objective calculation of the RV systolic function. The pulmonary artery systolic pressure (PAPs) was resultant from the tricuspid regurgitation (TR), added to right atrial pressure as assessed from the inferior vena cava diameter and collapsibility.

Standard features of echocardiography included parasternal (long/short axis), apical (2/4 chamber), and subxiphoid (long axis) that were recorded in all patients. In addition, LV ejection fraction (LVEF) was measured using Simpson method. The diameter of the right ventricle and left ventricle at the papillary muscle level, and their ratio in systole and diastole were measured in apical view (4 chamber).

RV fractional shortening was calculated by the following formula:

(RV end-diastolic diameter - RV end-systolic diameter) / RV end-diastolic diameter

Myocardial velocity in systolic and diastolic (early/late) in view of the apical (4 chamber) at the junction of the RV free wall and anterior cusp tricuspid valve (TV) was obtained with tissue Doppler imaging (TDI), and transmitral to basal septal myocardial early diastolic velocity ratio (E/Em) was measured.[@b8-ARYA-14-078]

The common method of evaluating the performance of the right ventricle through the tricuspid valve annulus is M-mode imaging using tricuspid annulus plain systolic excursion (TAPSE).

Data were analyzed for patients with completed data, and reported as mean ± standard deviation (SD) for continuous, and frequency (percent) for categorical variables. To compare qualitative variables between the groups, chi-square test was performed. Kolmogorov-Smirnov test was used for evaluating normal distribution of all quantitative parameters. Moreover, Student's t test was used for variables distributed in a normal way. Besides, Mann-Whitney test was performed for variables that had not normal distribution. Roc-curve was used in order to evaluate the diagnostic accuracy of studied variables in distinguishing pulmonary thromboembolism,8 and the optimal cut-off values were defined as the point at which the value of "sensitivity + specificity - 1"[@b9-ARYA-14-078],[@b10-ARYA-14-078] was maximum (Youden index). We used Pearson correlation to find correlation between studied variables. The two tailed p-value of less than 0.050 was considered significant. Statistical analysis of data was performed using SPSS software (version 20, SPSS Inc., Chicago, IL, USA).[@b11-ARYA-14-078],[@b12-ARYA-14-078]

Results
=======

Demographic features in terms of age (P = 0.446) and gender (P = 0.864) were similar in both groups. Ten patients were dropped out and finally, 150 patients completed the study. In patients with PTE and patients without PTE, 40.9% (n = 38) and 38.6% (n = 22) were men, respectively.

As is shown in [table 1](#t1-ARYA-14-078){ref-type="table"}, TAPSE was significantly lower in PTE group as compared to patients without PTE (P \< 0.001). Moreover, RV end-diastolic and end-systolic diameters in PTE group were significantly greater (P \< 0.001).

Whereas, LV end-diastolic diameter in patients with PTE was significantly lower than patients without PTE (P \< 0.001). Furthermore, we found that TV annulus TDI (E/E\') in patients without PTE was significantly lower as compared to patients with PTE (P \< 0.001). On the other hand, PAPs (P = 0.416) and RV fractional shortening (P = 0.157) were similar in both groups, and no statistically significance were observed.

According to [tables 2](#t2-ARYA-14-078){ref-type="table"} and [3](#t3-ARYA-14-078){ref-type="table"}, RV/LV (cut-off point: 0.6898) had the highest diagnostic accuracy in distinguishing PTE among the other studied variables with the sensitivity of 93.5%, specificity of 100%, positive predicting value (PPV) of 100%, and negative predictive value (NPV) of 90.47%. In following, PAP (cut-off point: 35.5) had the second place in the term of highest diagnostic accuracy in distinguishing PTE with sensitivity of 100%, specificity of 87.7%, PPV of 93%, and NPV of 100%.

In addition, we found that PACTOIR for patients with PET had a significant positive correlation with RV end-systolic diameter (Pearson correlation: 0.211). None of demographic and TTE results had significant differences in patients with different severity of PTE (P \> 0.050) ([Table 4](#t4-ARYA-14-078){ref-type="table"}).

Discussion
==========

Acute PTE is a disease with high prevalence, frequently underdiagnosed, treated poorly, and often associated with complications. Prognosis of PTE is related to the pre-existing cardiovascular disease, the degree of pulmonary hypertension and vascular obstruction, and mainly, to the presence of RV dysfunction.[@b13-ARYA-14-078] Current studies have been focused on performance of echocardiography to evaluate RV function in patients with PTE, which further helps to identify cases with a higher risk of morbidity and mortality, and in need of a more aggressive treatment.[@b14-ARYA-14-078]

PTE is associated with various signs and symptoms which may be mild or even absent, mainly in cases involving only the segmental pulmonary branches. Moreover, high or intermediate probability found based on clinical objective assessment, evokes the use of diagnostic techniques. However, a low probability based on objective clinical assessment does not exclude the need for further diagnosis. Further, maintaining a high level of suspicion by physicians is critical for diagnosis of PTE.

Our results showed that TAPSE was significantly lower in PTE group, as compared to patients without PTE (1.65 vs 2.00 cm). Vitarelli et al. study showed that TAPSE in patients with PTE was 1.5 cm, and 2.3 cm in patients without PTE.[@b15-ARYA-14-078] On the other hand, Gromadzinski et al. did not find any significant differences in TAPSE measurements between patients with and without PTE (1.45 vs 1.63 cm, P = 0.23).[@b16-ARYA-14-078]

Furthermore, TAPSE plays an important role as predictor of survival, regarding patients with PTE. However, no studies had before assessed interobserver reliability for this parameter. In the study of Kaul et al., TAPSE correlated powerfully with radionuclide angiography, with low interobserver variability.[@b13-ARYA-14-078] Even though, we did not evaluate variability of TAPSE in detecting PTE, TAPSE measurements were very low in patients with PTE, even lower than patients without PTE.

Moreover, TAPSE is a well-known, reproducible parameter that does not involve complex equipment and image analysis. In addition, this parameter has a proven prognostic value for detection of congestive heart failure. For patients with heart failure, decreased RV systolic function measured by TAPSE was found to be related to increased mortality, independent of other risk factors associated with this condition.[@b15-ARYA-14-078]

Furthermore, in a previous study, TAPSE was used to detect the severity of RV function defined by plasma B-type natriuretic peptide (BNP). A significant correlation was also found for plasma BNP level and TAPSE (r = −0.634, P \< 0.001).[@b16-ARYA-14-078] Interestingly, TAPSE measurement for lower reference value of RV function was recently stated as 16 mm. Moreover, TAPSE has been proposed as a prognostic tool on pulmonary arterial hypertension based on guidelines. In addition, TAPSE ≤ 15 is found to be an indicator of poor outcome.[@b16-ARYA-14-078],[@b17-ARYA-14-078] These studies and our show that patients with PTE had lower TAPSE, and having low amount of TAPSE has significant correlation with poor outcome in patients with PTE; which indicate that TAPSE measurement is a reliable factor in order to prove PTE, and outcome of these patients.

As obtained, RV end-diastolic diameter and RV end-systolic diameter in were significantly greater PTE group (3.41 vs 3.02 cm and 2.48 vs 2.16 cm, respectively), while end-systolic diameter in patients with PTE was significantly lower than patients without PTE (4.5 vs 5.4 cm). Gromadzinski et al. study showed that end-systolic diameter in patients with PTE was significantly lower than patients without PTE (4.5 vs 5.7 cm), while no significant correlation was found between RV end-diastolic diameter and PTE (3.4 vs 3.0 cm).[@b16-ARYA-14-078]

According to our findings, PACTOIR had significant positive correlation with RV end-systolic diameter. Moreover, in Varol et al. study, PACTOIR value for patients with RV dysfunction found to be significantly higher than those without RV dysfunction.[@b18-ARYA-14-078] Lastly, our results indicate that TV annulus TDI (E/E\') in patients without PTE was significantly lower, compared to patients with PTE (5.78 vs 6.02). Some studies showed that in patients with PTE, systolic and diastolic tricuspid annular velocities were significantly lower than in healthy controls.[@b18-ARYA-14-078]-[@b22-ARYA-14-078] There was a good reverse correlation between systolic TR velocity and systolic PAP (PAPs), as well as mean arterial PAP (PAPm), too.[@b23-ARYA-14-078]-[@b25-ARYA-14-078]

Conclusion
==========

Our results showed that TTE can be helpful in patients with signs or symptoms of PTE, as an alternative diagnostic method which determined the severity of this illness. We found significant differences in TAPSE, TV annulus TDI, RV end-diastolic diameter, and RV end-systolic and end-systolic diameters between the patients with PTE and without PTE that by defining scores for each of these factors, we could diagnosis PTE by using TTE. Moreover, we found that RV/LV in cut-off point of 0.6898, had the highest sensitivity, specificity, PPV, and NPV value in diagnosing PTE.
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###### 

Characteristics and transthoracic echocardiography (TTE) results of the study sample

  CT angiography results Variables             PTE (n = 93)    Without PTE (n = 57)   P
  -------------------------------------------- --------------- ---------------------- ----------
  Gender: Men \[n (%)\]                        38 (40.9)       22 (38.6)              0.864
  Age (year) \[Mean ± SD\]                     55.68 ± 4.19    56.26 ± 4.62           0.446
  TAPSE (cm) \[Mean ± SD\]                     1.65 ± 0.09     2.00 ± 0.08            \< 0.001
  TDI (E/E') \[Mean ± SD\]                     6.02 ± 0.10     5.78 ± 0.14            \< 0.001
  RVEDD (cm) \[Mean ± SD\]                     3.41 ± 0.09     3.02 ± 0.12            \< 0.001
  RVESD (cm) \[Mean ± SD\]                     2.48 ± 0.08     2.16 ± 0.06            \< 0.001
  LVEDD (cm) \[Mean ± SD\]                     4.54 ± 0.26     5.40 ± 0.24            \< 0.001
  PAP (mmHg) \[Mean ± SD\]                     25.00 ± 83.30   26.00 ± 86.70          0.416
  RV Fractional shortening (%) \[Mean ± SD\]   27.00 ± 2.70    27.64 ± 2.60           0.157
  RV/LV \[Mean ± SD\]                          0.75 ± 0.04     0.56 ± 0.03            \< 0.001
  PACTOIR \[Mean ± SD\]                        47.48 ± 6.53    \-                     \-

CT: Computed tomography; PTE: Pulmonary thromboembolism; SD: Standard deviation; TAPSE: Tricuspid annular plane systolic excursion; TDI: Tissue Doppler imaging; RVEDD: Right ventricular end-diastolic diameter; RVESD: Right ventricular end-systolic diameter; LVEDD: Left ventricular end-diastolic diameter; PAP: Pulmonary artery pressure; RV: Right ventricle; LV: Left ventricle; PACTOIR: Pulmonary artery computed tomography obstruction index ratio

###### 

Diagnostic accuracy of studied variables in detecting pulmonary thromboembolism (PTE)

  Variables                                                       TP   FP   TN   FN   Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)   LR^+^   LR^-^   Overall accuracy (%)
  --------------------------------------------------------------- ---- ---- ---- ---- ----------------- ----------------- --------- --------- ------- ------- ----------------------
  TDI (E/E') (cut-off point: 5.95; area: 0.947)                   75   0    57   18   80.6              100               100       76.00     \-      0.194   88.00
  PAP (cut-off point: 35.50; area: 0.880)                         93   7    50   0    100               87.7              93.00     100       8.13    0       95.33
  RV fractional shortening (cut-off point: 0.2419; area: 0.391)   83   45   12   10   89.2              21.1              64.84     54.54     1.13    0.510   63.33
  RV/LV (cut-off point 0.6889; area: 0.993)                       87   0    57   6    93.5              100               100       90.47     \-      0.065   96.00

PTE: Pulmonary thromboembolism; TP: True positive; FP: False positive; TN: True negative; FN: False negative; PPV: Positive predictive value; NPV: Negative predictive value; LR+: Positive likelihood; LR-: Negative likelihood; TDI: Tissue Doppler imaging; PAP: Pulmonary artery pressure; RV: Right ventricle; LV: Left ventricle

###### 

Pearson correlation between quantitative variables in patients with pulmonary thromboembolism (PTE)

                                           TAPSE    TDI(E/E')   RVEDD                                                 RVESD                                                  LVEDD                                                  PAP      RV fractional shortening                              RV/LV   PACTOIR
  -------------------------- ------------- -------- ----------- ----------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------ -------- ----------------------------------------------------- ------- ---------
  TAPSE                      Correlation   1        \-          \-                                                    \-                                                     \-                                                     \-       \-                                                    \-      \-
                             P             \-       \-          \-                                                    \-                                                     \-                                                     \-       \-                                                    \-      \-
  TDI (E/E')                 Correlation   0.051    1           \-                                                    \-                                                     \-                                                     \-       \-                                                    \-      \-
                             P             0.629    \-          \-                                                    \-                                                     \-                                                     \-       \-                                                    \-      \-
  RVEDD                      Correlation   0.054    -0.193      1                                                     \-                                                     \-                                                     \-       \-                                                    \-      \-
                             P             0.610    0.063       \-                                                    \-                                                     \-                                                     \-       \-                                                    \-      \-
  RVESD                      Correlation   0.039    -0.192      0.229[\*](#tfn3-ARYA-14-078){ref-type="table-fn"}     1                                                      \-                                                     \-       \-                                                    \-      \-
                             P             0.710    0.065       0.028                                                                                                        \-                                                     \-       \-                                                    \-      \-
  LVEDD                      Correlation   -0.082   -0.079      -0.143                                                -0.065                                                 1                                                      \-       \-                                                    \-      \-
                             P             0.434    0.454       0.173                                                 0.534                                                                                                         \-       \-                                                    \-      \-
  PAP                        Correlation   -0.002   -0.008      -0.049                                                -0.097                                                 0.119                                                  1        \-                                                    \-      \-
                             P             0.982    0.938       0.643                                                 0.354                                                  0.255                                                  \-       \-                                                    \-      \-
  RV fractional shortening   Correlation   0.002    0.029       0.523[\*\*](#tfn4-ARYA-14-078){ref-type="table-fn"}   -0.709[\*\*](#tfn4-ARYA-14-078){ref-type="table-fn"}   -0.047                                                 0.052    1                                                     \-      \-
                             P             0.984    0.779       \< 0.001                                              \< 0.001                                               0.653                                                  0.621    \-                                                    \-      \-
  RV/LV                      Correlation   0.084    -0.029      0.571[\*\*](#tfn4-ARYA-14-078){ref-type="table-fn"}   0.161                                                  -0.892[\*\*](#tfn4-ARYA-14-078){ref-type="table-fn"}   -0.124   0.273[\*\*](#tfn4-ARYA-14-078){ref-type="table-fn"}   1       \-
                             P             0.422    0.785       \< 0.001                                              0.123                                                  \< 0.001                                               0.235    0.008                                                 \-      \-
  PACTOIR                    Correlation   -0.054   -0.180      0.125                                                 0.211[\*](#tfn3-ARYA-14-078){ref-type="table-fn"}      0.007                                                  0.091    -0.094                                                0.064   1
                             P             0.610    0.084       0.234                                                 0.042                                                  0.946                                                  0.388    0.371                                                 0.544   \-

Correlation is significant at the 0.050 level (2-tailed);

Correlation is significant at the 0.010 level (2-tailed).

TAPSE: Tricuspid annular plane systolic excursion; TDI: Tissue Doppler imaging; RVEDD: Right ventricular end-diastolic diameter; RVESD: Right ventricular end-systolic diameter; LVEDD: Left ventricular end-diastolic diameter; PAP: Pulmonary artery pressure; RV: Right ventricle; LV: Left ventricle; PACTOIR: Pulmonary artery computed tomography obstruction index ratio

###### 

Characteristics and transthoracic echocardiography (TTE) results in patients with pulmonary thromboembolism (PTE) based on PTE severity

  PTE severity Variables                       Mild to moderate (n = 15)   Moderate to severe (n = 78)   P
  -------------------------------------------- --------------------------- ----------------------------- -------
  Gender: Men \[n (%)\]                        8 (53.3)                    30 (38.5)                     0.283
  Age (year) \[Mean ± SD\]                     55.66 ± 4.01                55.69 ±4.25                   0.983
  TAPSE (cm) \[Mean ± SD\]                     1.66 ± 0.08                 1.65 ± 0.10                   0.971
  TDI (E/E') \[Mean ± SD\]                     6.07 ± 0.08                 6.02 ± 0.11                   0.088
  RVEDD (cm) \[Mean ± SD\]                     3.40 ± 0.09                 3.41 ± 0.09                   0.594
  RVESD (cm) \[Mean ± SD\]                     2.44 ± 0.14                 2.49 ± 0.06                   0.191
  LVEDD (cm) \[Mean ± SD\]                     4.51 ± 0.07                 4.55 ± 0.28                   0.578
  PAP (mmHg) \[Mean ± SD\]                     36.93 ± 0.45                38.55 ± 4.99                  0.215
  RV Fractional shortening (%) \[Mean ± SD\]   27.00 ±4.00                 26.00 ± 2.00                  0.337
  RV/LV \[Mean ± SD\]                          0.75 ± 0.01                 0.75 ± 0.04                   0.928

PTE: Pulmonary thromboembolism; TAPSE: Tricuspid annular plane systolic excursion; TDI: Tissue Doppler imaging; RVEDD: Right ventricular end-diastolic diameter; RVESD: Right ventricular end-systolic diameter; LVEDD: Left ventricular end-diastolic diameter; PAP: Pulmonary artery pressure; RV: Right ventricle; LV: Left ventricle; SD: Standard deviation
